Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
Hisataka Yasuda(SHOWA Medical University), Kanji Higashio(Megmilk Snow Brand (Japan)), Shin-ichi Mochizuki(Megmilk Snow Brand (Japan)), Takeshi Kanno(Jichi Medical University), Masaaki Goto(SHOWA Medical University), Toshio Suda(Chinese Academy of Sciences), Masayoshi Kuriyama(Megmilk Snow Brand (Japan)), Akihiko Murakami(SHOWA Medical University), Yasushi Sato(Megmilk Snow Brand (Japan)), Kazuki Yano(SHOWA Medical University), Kyoji Yamaguchi(Daiichi-Sankyo (Japan)), Tomonori Morinaga(SHOWA Medical University), Nobuaki Fujise(Megmilk Snow Brand (Japan)), Nobuyuki Shima(SHOWA Medical University), N. Nakagawa(SHOWA Medical University)
Cited by 1,209
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis
|Biochemical and Biophysical Research Communications|1998|746